Opus Genetics, Inc. (IRD) — Defensive Interval Ratio

Latest as of December 2025: 148 days

Opus Genetics, Inc. (IRD) has a Defensive Interval Ratio of 148 days as of December 2025. Defensive assets of $3.17 Million (cash $-, short-term investments $0.00, receivables $3.17 Million) cover 148 days of daily cash needs of $21.32K/day. Check tangible equity quality of Opus Genetics, Inc. to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

148 days
Days of operational coverage

Defensive Assets

$3.17 Million
Cash + ST Investments + Receivables

Daily Cash Need

$21.32K
Current Liabilities ÷ 365

Current Liabilities

$7.78 Million
USD

Opus Genetics, Inc. Defensive Interval Ratio (2019–2025)

This chart shows how Opus Genetics, Inc.'s Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the ratio stands at 148 days, meaning defensive assets of $3.17 Million can fund 148 days of operations without new revenue. Also explore Opus Genetics, Inc. annual equity growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Opus Genetics, Inc. (2019–2025)

The table below presents the year-by-year Defensive Interval Ratio for Opus Genetics, Inc. from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Opus Genetics, Inc..

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 148 days $3.17 Million $21.32K/day $- $0.00 ▼ -38 days
2024 187 days $5.77 Million $30.95K/day $- $2.00K ▼ -25 days
2023 212 days $2.35 Million $11.07K/day $- $15.00K ▼ -437 days
2022 650 days $4.90 Million $7.54K/day $- $49.00K ▲ +629 days
2021 21 days $219.00K $10.56K/day $- $219.00K ▲ +21 days
2020 0 days $0.00 $8.73K/day $- $0.00 ▼ -5 days
2019 5 days $125.00K $25.60K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)